2024 Radiosurgery Society Meeting shows high-risk prostate cancer effectively treated in 5 days with Accuray's CyberKnife System.

New data from two clinical studies show high-risk and recurrent prostate cancers can be effectively treated in 5 days using Accuray's CyberKnife® System. The studies highlight the potential benefits of the system's sub-millimeter accuracy in preserving quality of life after treatment for prostate cancer. The findings were presented at the 2024 Radiosurgery Society Meeting in Chicago, Illinois.